Suppression of LPS-Induced Inflammation and Cell Migration by Azelastine through Inhibition of JNK/NF-κB Pathway in BV2 Microglial Cells

Autor: Bich Phuong Bui, Men Thi Hoai Duong, Kyeong Lee, Hee-Chul Ahn, Jungsook Cho, Phuong Linh Nguyen
Rok vydání: 2021
Předmět:
Lipopolysaccharides
Lipopolysaccharide
Anti-Inflammatory Agents
Nitric Oxide Synthase Type II
Pharmacology
neuroinflammation
chemistry.chemical_compound
Mice
Cell Movement
Biology (General)
Spectroscopy
c-Jun N-terminal kinase
drug repurposing
Kinase
NF-kappa B
Cell migration
General Medicine
Computer Science Applications
Chemistry
Phosphorylation
Tumor necrosis factor alpha
Microglia
medicine.symptom
Inflammation Mediators
Signal Transduction
JNK inhibitor
structure-based virtual screening
QH301-705.5
MAP Kinase Signaling System
Inflammation
BV2 microglial cells
Nitric Oxide
Catalysis
Article
Cell Line
Inorganic Chemistry
medicine
Animals
nuclear factor-kappa B (NF-κB)
Physical and Theoretical Chemistry
Molecular Biology
QD1-999
Neuroinflammation
Interleukin-6
Tumor Necrosis Factor-alpha
Organic Chemistry
JNK Mitogen-Activated Protein Kinases
NF-κB
chemistry
azelastine
Phthalazines
Zdroj: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 9061, p 9061 (2021)
Volume 22
Issue 16
ISSN: 1422-0067
Popis: The c-Jun N-terminal kinases (JNKs) are implicated in many neuropathological conditions, including neurodegenerative diseases. To explore potential JNK3 inhibitors from the U.S. Food and Drug Administration-approved drug library, we performed structure-based virtual screening and identified azelastine (Aze) as one of the candidates. NMR spectroscopy indicated its direct binding to the ATP-binding site of JNK3, validating our observations. Although the antihistamine effect of Aze is well documented, the involvement of the JNK pathway in its action remains to be elucidated. This study investigated the effects of Aze on lipopolysaccharide (LPS)-induced JNK phosphorylation, pro-inflammatory mediators, and cell migration in BV2 microglial cells. Aze was found to inhibit the LPS-induced phosphorylation of JNK and c-Jun. It also inhibited the LPS-induced production of pro-inflammatory mediators, including interleukin-6, tumor necrosis factor-α, and nitric oxide. Wound healing and transwell migration assays indicated that Aze attenuated LPS-induced BV2 cell migration. Furthermore, Aze inhibited LPS-induced IκB phosphorylation, thereby suppressing nuclear translocation of NF-κB. Collectively, our data demonstrate that Aze exerts anti-inflammatory and anti-migratory effects through inhibition of the JNK/NF-κB pathway in BV2 cells. Based on our findings, Aze may be a potential candidate for drug repurposing to mitigate neuroinflammation in various neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases.
Databáze: OpenAIRE